The chromatin-organizer Satb1 modulates regulatory T cell activity within the tumor microenvironment
Open Access
- 7 October 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
No abstract availableKeywords
Funding Information
- Pelotonia Institute for Immuno-Oncology
This publication has 84 references indexed in Scilit:
- Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and PitfallsAnnals of Oncology, 2026
- Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapyCellular Oncology, 2025
- Discovery of a proteolysis targeting chimera (PROTAC) as a potent regulator of FOXP3Bioorganic & Medicinal Chemistry Letters, 2024
- Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitorsCancer Medicine, 2024
- Tumor-infiltrating regulatory T cells as targets of cancer immunotherapyCancer Cell, 2023
- Immune-related adverse events in various organs caused by immune checkpoint inhibitorsAllergology International, 2022
- Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 BlockadeCell, 2018
- Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint BlockadeCell, 2017
- Essential Roles of SATB1 in Specifying T Lymphocyte SubsetsCell Reports, 2017
- Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine ColitisCell Reports, 2016